Trafalgar International, Inc. (GCAN): Operating Income
-$183.0K
Year ended 2025-12-31
-$136.1K
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$183.0K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$156.3K | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$175.4K | n/m | 2025-05-05, From 2023-01-01 |
| 2022-12-31 | -$177.0K | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$343.1K | n/m | 2023-04-13, From 2021-01-01 |
| 2020-12-31 | -$294.5K | n/m | 2022-04-12, From 2020-01-01 |
| 2019-12-31 | -$525.3K | n/m | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$190.9K | n/m | 2020-04-14, From 2018-01-01 |
| 2017-12-31 | -$622.6K | n/m | 2018-04-26, From 2017-01-01 |
| 2016-12-31 | -$100.0K | n/a | 2018-04-26, From 2016-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Trafalgar International, Inc. (GCAN) | 2025-12-31 | -$183.0K | n/m |
| CNBX Pharmaceuticals Inc. (CNBX) | 2025-08-31 | -$271.7K | n/m |
| Nika Pharmaceuticals, Inc (NIKA) | 2025-12-31 | -$76.4K | n/m |
| One World Products, Inc. (OWPC) | 2024-12-31 | -$1.87M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$496.3K | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$1.04M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$338.5K | n/m |
| Cell Source, Inc. (CLCS) | 2024-12-31 | -$3.84M | n/m |
| America Great Health (AAGH) | 2025-06-30 | -$382.9K | n/m |
Compare GCAN, CNBX, NIKA, OWPC side by side · Screen every company in Pharmaceutical Preparations ↗